September 13, 2015
European Commission approves Tafinlar and Mekinist combination
The European Commission has approved the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) for the treatment of adult patients with…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: BRAF mutation